Prophylaxis of obstetric and perinatal complications in pregnant women after in vitro fertilization with thyroid pathology

Authors: Romanenko T., Chayka O., P. Shupik National Medical Academy of Postgraduate Education of the Ministry of Health of Ukraine, Kiev, Ukraine


Abstract

Studied during pregnancy, childbirth, postpartum, thyroid function, fetoplacental complex in women living in the Kiev region. The studies demonstrate the features of the thyroid gland, manifested in a slight decrease in the average level of free thyroxine fractions, triiodothyronine. Increased levels of placental lactogen, which provides high functional activity of the placenta in the second trimester indicates stress adaptation and compensatory mechanisms of the body. A direct correlation pituitary-tyreoidnoyi and placental systems. In order to prevent iodine deficiency status of the mother, fetus and newborn, placental dysfunction and thyroid medication is recommended to correct complex Yodofol, which contains potassium iodide and folic acid of early pregnancy.

Keywords: pregnancy, thyroid function, iodine deficiency, fetoplacental complex, placental dysfunction, prevention of hypothyroidism, Yodofol.

ARTICLES FROM CATEGORY
Support of educational events. Participation of World Medicine in the First Congress of Optometrists of Ukraine.
Cetirizine is an effective and safe antihistamine (literature review, results of clinical researches)
All-Ukrainian Scientific and Practical Conference “Aspects of Internal Medicine in Wartime 2024"

PROVE YOU ARE A MEDICAL PROFESSIONAL

Attention: This section is intended for healthcare professionals only. If you are not a medical professional, you can return to the main page by clicking the “No” option

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design